Porphyrias, porphyrins and hepatocellular cancer.

por Bengtsson, N. O., Hardell, L.
Publicado 1986

Epidemiological study of socioeconomic factors and clinical findings in Hodgkin's disease, and reanalysis of previous data regarding chemical exposure.

por Hardell, L., Bengtsson, N. O.
Publicado 1983

Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation.

por Hardell, L., Bengtsson, N. O., Jonsson, U., Eriksson, S., Larsson, L. G.
Publicado 1984

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

por Stendahl, M, Kronblad, Å, Rydén, L, Emdin, S, Bengtsson, N O, Landberg, G
Publicado 2004

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

por Carlsson, J, Nordgren, H, Sjöström, J, Wester, K, Villman, K, Bengtsson, N O, Ostenstad, B, Lundqvist, H, Blomqvist, C
Publicado 2004

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

por Rosell, J, Nordenskjöld, B, Bengtsson, N-O, Fornander, T, Hatschek, T, Lindman, H, Malmström, P-O, Wallgren, A, Stål, O, Carstensen, J
Publicado 2011

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients

por Tynninen, O, Sjöström, J, von Boguslawski, K, Bengtsson, N O, Heikkilä, R, Malmström, P, Østenstad, B, Wist, E, Valvere, V, Saksela, E, Paavonen, T, Blomqvist, C
Publicado 2002